title: Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains.
abstract: We have undertaken an integrated chemical and morphological comparison of the amyloid-beta (Abeta) molecules and the amyloid plaques present in the brains of APP23 transgenic (tg) mice and human Alzheimer's disease (AD) patients. Despite an apparent overall structural resemblance to AD pathology, our detailed chemical analyses revealed that although the amyloid plaques characteristic of AD contain cores that are highly resistant to chemical and physical disruption, the tg mice produced amyloid cores that were completely soluble in buffers containing SDS. Abeta chemical alterations account for the extreme stability of AD plaque core amyloid. The corresponding lack of post-translational modifications such as N-terminal degradation, isomerization, racemization, pyroglutamyl formation, oxidation, and covalently linked dimers in tg mouse Abeta provides an explanation for the differences in solubility between human AD and the APP23 tg mouse plaques. We hypothesize either that insufficient time is available for Abeta structural modifications or that the complex species-specific environment of the human disease is not precisely replicated in the tg mice. The appraisal of therapeutic agents or protocols in these animal models must be judged in the context of the lack of complete equivalence between the transgenic mouse plaques and the human AD lesions.
authors.affiliation: Longtine Center for Molecular Biology and Genetics and the Civin Laboratory of Neuropathology, Sun Health Research Institute, Sun City, Arizona 85351, USA.
authors.forename: Y M
authors.initials: YM
authors.lastname: Kuo
authors.forename: T A
authors.initials: TA
authors.lastname: Kokjohn
authors.forename: T G
authors.initials: TG
authors.lastname: Beach
authors.forename: L I
authors.initials: LI
authors.lastname: Sue
authors.forename: D
authors.initials: D
authors.lastname: Brune
authors.forename: J C
authors.initials: JC
authors.lastname: Lopez
authors.forename: W M
authors.initials: WM
authors.lastname: Kalback
authors.forename: D
authors.initials: D
authors.lastname: Abramowski
authors.forename: C
authors.initials: C
authors.lastname: Sturchler-Pierrat
authors.forename: M
authors.initials: M
authors.lastname: Staufenbiel
authors.forename: A E
authors.initials: AE
authors.lastname: Roher
mesh_terms: D000544:Alzheimer Disease / Q000378:metabolism* / Q000473:pathology; D000595:Amino Acid Sequence; D000682:Amyloid / Q000737:chemistry*; D016229:Amyloid beta-Peptides / Q000737:chemistry* / Q000235:genetics / Q000302:isolation & purification; D000818:Animals; D001921:Brain / Q000473:pathology; D001923:Brain Chemistry; D002851:Chromatography, High Pressure Liquid; D003488:Cyanogen Bromide; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D008970:Molecular Weight; D010446:Peptide Fragments / Q000737:chemistry; D058225:Plaque, Amyloid / Q000737:chemistry / Q000473:pathology; D014357:Trypsin
chemical_list: D000682:Amyloid; D016229:Amyloid beta-Peptides; D010446:Peptide Fragments; D014357:Trypsin; D003488:Cyanogen Bromide